These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 415967)

  • 61. Evaluation of effector cells mediating the antitumor action of glucan.
    Cook JA; Taylor D; Cohen C; Hoffmann EO; Rodrigue J; Malshet V; Di Luzio NR
    J Reticuloendothel Soc; 1977 Jul; 22(1):21-34. PubMed ID: 330854
    [No Abstract]   [Full Text] [Related]  

  • 62. Quantitative approaches to the assessment of cell-mediated immune responses to solid tumor allografts.
    MacDonald HR; Lees RK; Howell RL
    Transplant Proc; 1978 Jun; 10(2):339-42. PubMed ID: 97826
    [No Abstract]   [Full Text] [Related]  

  • 63. Non-specific cytotoxicity of spleen cells in mice bearing transplanted chemically induced fibrosarcomas.
    Mantovani A; Evans R; Alexander P
    Br J Cancer; 1977 Jul; 36(1):35-40. PubMed ID: 889683
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Some characteristics of natural cytostatic mouse splenocytes.
    Ehrlich R; Efrati M; Witz IP
    J Immunol Methods; 1981; 40(2):193-208. PubMed ID: 7252160
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The cryopreservation of immunocompetent cells.
    Grant CK; Powles R
    Cryobiology; 1973 Sep; 10(4):290-4. PubMed ID: 4542998
    [No Abstract]   [Full Text] [Related]  

  • 66. The decay of memory of cell-mediated cytotoxicity after primary sensitization in vivo against a tumor allograft.
    Jones KH; Adler WH
    Immunol Commun; 1978; 7(6):645-59. PubMed ID: 154468
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Non-T-cell resistance against a mouse Moloney lymphoma.
    Kiessling R; Petrányi G; Klein G; Wigzell H
    Int J Cancer; 1976 Feb; 17(2):275-81. PubMed ID: 1082449
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Augmentation of cell-mediated cytotoxicity following 50% partial hepatectomy.
    Flye MW; Yu S
    Transplantation; 1990 Mar; 49(3):581-7. PubMed ID: 2316018
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cell-mediated cytotoxicity against syngeneic tumors.
    Sinclair NR; McFarlane DL; Low JM
    Cell Immunol; 1981 Apr; 59(2):330-44. PubMed ID: 6793241
    [No Abstract]   [Full Text] [Related]  

  • 70. Nonspecific cytotoxicity of spleen cells and the specific cytotoxic action of thymus-derived lymphocytes in vitro.
    Grant CK; Alexander P
    Cell Immunol; 1974 Oct; 14(1):46-51. PubMed ID: 4549557
    [No Abstract]   [Full Text] [Related]  

  • 71. Modulation of natural cytotoxicity by alloantibodies. V. The mechanism of a selective augmenting effect of anti-H-2 antisera on the natural killer activity of mouse spleen cells.
    Saxena RK; Saxena QB; Adler WH
    Cell Immunol; 1981 Nov; 65(1):115-30. PubMed ID: 6797740
    [No Abstract]   [Full Text] [Related]  

  • 72. Detection of cytotoxic T-lymphocytes in tumour bearing animals: procedures to isolate highly active populations.
    Vasudevan DM; Vijayakumar T
    Indian J Cancer; 1977 Dec; 14(4):354-60. PubMed ID: 306380
    [No Abstract]   [Full Text] [Related]  

  • 73. Genetic variation of in vitro cytolytic activity and in vivo rejection potential of non-immunized semi-syngeneic mice against a mouse lymphoma line.
    Kiessling R; Petranyi G; Klein G; Wigzel H
    Int J Cancer; 1975 Jun; 15(6):933-40. PubMed ID: 1150347
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The differentiation pathway of T lymphocytes. Evidence for two differentiated cell types.
    Matter A
    J Exp Med; 1974 Aug; 140(2):566-77. PubMed ID: 4152545
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Hybrids between rat lymphoma and mouse T cells with inducible cytolytic activity.
    Conzelmann A; Corthésy P; Cianfriglia M; Silva A; Nabholz M
    Nature; 1982 Jul; 298(5870):170-2. PubMed ID: 6979720
    [No Abstract]   [Full Text] [Related]  

  • 76. Allograft cytotoxicity: critical role for adherent T cells in effector mechanism of the peritoneal population.
    Jones B; Penfold P
    Cell Immunol; 1979 Sep; 46(2):259-74. PubMed ID: 114306
    [No Abstract]   [Full Text] [Related]  

  • 77. Cells mediating specific in vitro cytotoxicity. I. Detection of receptor-bearing lymphocytes.
    Golstein P; Erik MD; Svedmyr AJ; Wigzell H
    J Exp Med; 1971 Dec; 134(6):1385-402. PubMed ID: 5001703
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Influence of Ara-C on effector activity of cytotoxic T-lymphocytes in vitro.
    Migliorati G; Frati L; Barzi A; Bonmassar E
    J Immunopharmacol; 1981; 3(1):17-27. PubMed ID: 6972977
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Low numbers of tumor cells suppress the host immune system.
    Kölsch E; Mengersen R
    Adv Exp Med Biol; 1976; 66():431-6. PubMed ID: 817574
    [No Abstract]   [Full Text] [Related]  

  • 80. In vitro induction of tumour-specific immunity. I. Development of optimal conditions for induction and assay of cytotoxic lymphocytes.
    Burton R; Thompson J; Warner NL
    J Immunol Methods; 1975; 8(1-2):133-49. PubMed ID: 807654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.